Developing mentors and leaders in gulf gastroenterology: the Gastroleaders framework.

IF 3.3 3区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY

Expert Review of Gastroenterology & Hepatology Pub Date : 2026-10-15 DOI:10.1080/17474124.2026.2745666

Eyad Gadour, Mohamed Fathy Guda, Diamond Joy, Emad S Aljahdl, Mohammed Albeshir, Ibrahim Alhafid, Abdulrahman Alfadda, Fuad Muafa, Abdullah Alotaibi, Turki Alamri, Syed Anjum Gardezi, Abed Al-Lehibi

{"title":"Developing mentors and leaders in gulf gastroenterology: the Gastroleaders framework.","authors":"Eyad Gadour, Mohamed Fathy Guda, Diamond Joy, Emad S Aljahdl, Mohammed Albeshir, Ibrahim Alhafid, Abdulrahman Alfadda, Fuad Muafa, Abdullah Alotaibi, Turki Alamri, Syed Anjum Gardezi, Abed Al-Lehibi","doi":"10.1080/17474124.2026.2745666","DOIUrl":null,"url":null,"abstract":"Introduction: Gulf Cooperation Council (GCC) gastroenterology services are expanding, but published evidence on structured specialty-specific mentorship and leadership development remains uneven and is concentrated in a small number of countries.Areas covered: This critical perspective distinguishes the proposed GastroLeaders leadership-and-mentorship intervention from clinical education and independent procedural accreditation. PubMed/MEDLINE was searched from inception through 31 August 2026 using terms for mentorship, leadership, gastroenterology training, hepatology, inflammatory bowel disease (IBD), motility and endoscopy; official society and regulator websites were checked through early September 2026. The paper provides a six-country situational analysis, uses the UK JRCPTB/JAG system as an adaptable, not flawless, exemplar, expands priorities in hepatology, inflammatory bowel disease, neurogastroenterology and motility, advanced endoscopy, nutrition and communication, and specifies a prospective multicentre pilot with SMART targets, validated measures, cost and equity indicators, and 24-month follow-up.Expert opinion: GastroLeaders should first be tested as a bounded, cross-specialty-compatible professional-development program. Scale-up should depend on predefined feasibility, equity and effectiveness thresholds; clinical credentials must remain with recognized national and procedural authorities.","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"1-10"},"PeriodicalIF":3.3000,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474124.2026.2745666","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Gulf Cooperation Council (GCC) gastroenterology services are expanding, but published evidence on structured specialty-specific mentorship and leadership development remains uneven and is concentrated in a small number of countries.

Areas covered: This critical perspective distinguishes the proposed GastroLeaders leadership-and-mentorship intervention from clinical education and independent procedural accreditation. PubMed/MEDLINE was searched from inception through 31 August 2026 using terms for mentorship, leadership, gastroenterology training, hepatology, inflammatory bowel disease (IBD), motility and endoscopy; official society and regulator websites were checked through early September 2026. The paper provides a six-country situational analysis, uses the UK JRCPTB/JAG system as an adaptable, not flawless, exemplar, expands priorities in hepatology, inflammatory bowel disease, neurogastroenterology and motility, advanced endoscopy, nutrition and communication, and specifies a prospective multicentre pilot with SMART targets, validated measures, cost and equity indicators, and 24-month follow-up.

Expert opinion: GastroLeaders should first be tested as a bounded, cross-specialty-compatible professional-development program. Scale-up should depend on predefined feasibility, equity and effectiveness thresholds; clinical credentials must remain with recognized national and procedural authorities.

查看原文本刊更多论文

发展海湾胃肠病学的导师和领导者：胃肠领导者框架。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Gastroenterology & Hepatology GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

6.80

自引率

2.60%

发文量

审稿时长

6-12 weeks

期刊介绍： The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.